Obesity: Health Services

(asked on 3rd September 2025) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his Department's publication entitled 10 Year Health Plan for England: fit for the future, published on 3 July 2025, what progress his Department has made on the digital-only delivery of weight loss (a) services and (b) treatments; and if his Department will publish further details on how it plans to test innovative models for those services and treatments.


Answered by
Ashley Dalton Portrait
Ashley Dalton
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 11th September 2025

We are committed to expanding access to weight management services through digital innovation and personalised pathways that support people in a way that best meets their needs.

The NHS Digital Weight Management Programme is the only nationally commissioned weight management service delivered entirely through digital means. As set out in the 10-Year Health Plan, there is a clear commitment to expand access to this programme, including doubling referral volumes. The service went live in 2021, and active planning is now underway to deliver this expansion, which is expected to begin in 2026/27.

For pharmacological treatments such as tirzepatide, otherwise know as Mounjaro, for the management of obesity, NHS England is working with the Office for Life Sciences and other partners to develop digitally enabled care pathways supported by behavioural interventions and which place patient safety and clinical oversight at their core. This is part of the newly launched £85 million health innovation programme, in collaboration with Eli Lilly, to test novel delivery models for weight management. These include digital platforms, pharmacy-led services, and community-based access routes. The programme is designed to improve accessibility and reduce pressure on specialist services, whilst ensuring care is safe and aligned with national clinical standards.

These innovative pathways are being designed to bring together remote prescribing, personalised behavioural support, and ongoing clinical supervision, allowing patients to access high-quality care in a way that is convenient and tailored to their individual needs.

Reticulating Splines